Rajiv de Silva, President & COO Spec. Pharma at Valeant Pharmaceuticals International, Inc. (VRX), sold 219,897 shares at $27.00 ($5.9M) on 2010-12-01, disclosed to the SEC on 2010-12-02.
Scheduled sale ($5.9M) by President & COO Spec. Pharma under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 18,277 | $493K | 8.3% |
| 2 | $27.00 | 201,620 | $5.4M | 91.7% |
| Total | $27.00 avg | 219,897 | $5.9M | 100% |
| Filing → |
| ENDP | BUY | 2015-11-12 | $500K | — | Filing → |
| VRX | SELL | 2012-11-09 | $4.1M | — | Filing → |
| VRX | SELL | 2012-11-08 | $12.0M | — | Filing → |